Company intelligence / Profile preview

Proto Gabiotech

Xiamen, Fujian, China

Ownership: Private
Employees: ~50
Development stage: Other

Overview

Protoga Biotech is a synthetic biology company focused on the sustainable production of high-value bio-based materials using microalgae. The company leverages advanced genetic engineering and fermentation technologies to develop products for the healthcare, nutrition, and personal care industries. Their portfolio includes vegan-sourced Omega-3 fatty acids (DHA/EPA), carotenoids, and specialized proteins produced through carbon-neutral processes. Protoga aims to replace traditional chemical synthesis and animal-derived ingredients with eco-friendly, microalgae-based alternatives.

Modalities: Microbial therapyBiologicSmall molecule
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Proto Gabiotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Proto Gabiotech.

Explore the full profile